Non-coding RNAs As Therapeutic Targets in Cancer and Its Clinical Application

Overview

Journal J Pharm Anal

Specialty Chemistry

Date 2024 Aug 16

PMID 39149142

Authors

XueJiao Leng

Mengyuan Zhang

Yujing Xu

Jingjing Wang

Ning Ding

Yancheng Yu

Shanliang Sun

Weichen Dai

Xin Xue

Nianguang Li

Ye Yang

Zhihao Shi

Affiliations

Soon will be listed here.

Abstract

Cancer genomics has led to the discovery of numerous oncogenes and tumor suppressor genes that play critical roles in cancer development and progression. Oncogenes promote cell growth and proliferation, whereas tumor suppressor genes inhibit cell growth and division. The dysregulation of these genes can lead to the development of cancer. Recent studies have focused on non-coding RNAs (ncRNAs), including circular RNA (circRNA), long non-coding RNA (lncRNA), and microRNA (miRNA), as therapeutic targets for cancer. In this article, we discuss the oncogenes and tumor suppressor genes of ncRNAs associated with different types of cancer and their potential as therapeutic targets. Here, we highlight the mechanisms of action of these genes and their clinical applications in cancer treatment. Understanding the molecular mechanisms underlying cancer development and identifying specific therapeutic targets are essential steps towards the development of effective cancer treatments.

Citing Articles

The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.

Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R Research (Wash D C). 2025; 8:0612.

PMID: 40046513 PMC: 11880593. DOI: 10.34133/research.0612.

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.

Alalhareth I, Alyami S, Alshareef A, Ajeibi A, Al Munjem M, Elfifi A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006021 PMC: 11858621. DOI: 10.3390/ph18020207.

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms.

Krejcik Z, Kundrat D, Klema J, Hrustincova A, Trsova I, Belickova M Biomark Res. 2025; 13(1):13.

PMID: 39849644 PMC: 11755807. DOI: 10.1186/s40364-025-00725-x.

Eugenol inhibits NEAT1 as a ceRNA in pre-cancerous breast lesions.

Liu Y, Zhang G, Ma Y, Ma M, Jiang X Heliyon. 2025; 11(1):e41353.

PMID: 39811361 PMC: 11732537. DOI: 10.1016/j.heliyon.2024.e41353.

Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.

References

Li S, Weng J, Song F, Li L, Xiao C, Yang W . Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. Cell Death Dis. 2020; 11(6):452. PMC: 7293356. DOI: 10.1038/s41419-020-2616-8. View

Tang W, Ji M, He G, Yang L, Niu Z, Jian M . Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7. Onco Targets Ther. 2017; 10:2045-2056. PMC: 5391170. DOI: 10.2147/OTT.S131597. View

Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View

Wang J, Li T, Wang B . Circ-UBAP2 functions as sponges of miR-1205 and miR-382 to promote glioma progression by modulating STC1 expression. Cancer Med. 2021; 10(5):1815-1828. PMC: 7940226. DOI: 10.1002/cam4.3759. View

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

Yang A, Liu X, Liu P, Feng Y, Liu H, Gao S . LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. Cell Mol Biol Lett. 2021; 26(1):33. PMC: 8268585. DOI: 10.1186/s11658-021-00275-8. View

Muniyappa M, Dowling P, Henry M, Meleady P, Doolan P, Gammell P . MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer. 2009; 45(17):3104-18. DOI: 10.1016/j.ejca.2009.09.014. View

Li Z, Lu X, Liu Y, Zhao J, Ma S, Yin H . Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex. Hepatology. 2020; 73(5):1764-1782. DOI: 10.1002/hep.31530. View

Rampazzo E, Del Bianco P, Bertorelle R, Boso C, Perin A, Spiro G . The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients. Br J Cancer. 2018; 118(6):878-886. PMC: 5877438. DOI: 10.1038/bjc.2017.492. View

10.

Zeng X, Xie H, Yuan J, Jiang X, Yong J, Zeng D . M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther. 2019; 20(7):956-966. PMC: 6606001. DOI: 10.1080/15384047.2018.1564567. View

11.

Kim D, Rossi J . RNAi mechanisms and applications. Biotechniques. 2008; 44(5):613-6. PMC: 2727154. DOI: 10.2144/000112792. View

12.

Han B, Shaolong E, Luan L, Li N, Liu X . CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis via Altering of miR-508-3p/CXCL13 Signal. Onco Targets Ther. 2020; 13:6051-6062. PMC: 7422843. DOI: 10.2147/OTT.S251436. View

13.

Liu S, Yang J, Cao D, Shen K . Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med. 2014; 10(3):138-41. PMC: 3860336. DOI: 10.7497/j.issn.2095-3941.2013.03.003. View

14.

Du L, Schageman J, Subauste M, Saber B, Hammond S, Prudkin L . miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 2009; 7(8):1234-43. PMC: 2741087. DOI: 10.1158/1541-7786.MCR-08-0507. View

15.

Xie J, Liu M, Li Y, Nie Y, Mi Q, Zhao S . Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. Cell Mol Immunol. 2014; 11(5):495-502. PMC: 4197204. DOI: 10.1038/cmi.2014.30. View

16.

Krawczyk M, Emerson B . p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife. 2014; 3:e01776. PMC: 4017649. DOI: 10.7554/eLife.01776. View

17.

Li T, Sun X, Chen L . Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2019; 121(3):2118-2126. DOI: 10.1002/jcb.28239. View

18.

Huang C, Deng H, Wang Y, Jiang H, Xu R, Zhu X . Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression. J Cell Mol Med. 2019; 23(9):6112-6119. PMC: 6714494. DOI: 10.1111/jcmm.14477. View

19.

Shen Z, Zhou L, Zhang C, Xu J . Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2019; 468:88-101. DOI: 10.1016/j.canlet.2019.10.006. View

20.

Liu C, Hu W, Li L, Wang Y, Zhou Q, Zhang F . Roles of miR-200 family members in lung cancer: more than tumor suppressors. Future Oncol. 2018; 14(27):2875-2886. DOI: 10.2217/fon-2018-0155. View